Broad-Spectrum Cephalosporin-Resistant Klebsiella spp. Isolated from Diseased Horses in Austria. 2020

Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
Institute of Microbiology, University of Veterinary Medicine, 1210 Vienna, Austria.

The aim of the present study was to investigate the diversity of broad-spectrum cephalosporin-resistant Klebsiella spp. isolated from horses in Austria that originated from diseased horses. A total of seven non-repetitive cefotaxime-resistant Klebsiella sp. isolates were obtained during diagnostic activities from autumn 2012 to October 2019. Antimicrobial susceptibility testing was performed. The isolates were genotyped by whole-genome sequencing (WGS). Four out of seven Klebsiella isolates were identified as K. pneumoniae, two as K. michiganensis and one as K. oxytoca. All isolates displayed a multi-drug resistant phenotype. The detection of resistance genes reflected well the phenotypic resistance profiles of the respective isolates. All but one isolate displayed the extended-spectrum β-lactamases (ESBL) phenotype and carried CTX-M cefotaximases, whereas one isolate displayed an ESBL and AmpC phenotype and carried cephamycinase (CMY)-2 and sulfhydryl variable (SHV)-type b and Temoniera (TEM) β-lactamases. Among Klebsiella pneumoniae isolates, for different sequence types (ST) could be detected (ST147, ST307, ST1228, and a new ST4848). Besides resistance genes, a variety of virulence genes, including genes coding for yersiniabactin were detected. Considering the high proximity between horses and humans, our results undoubtedly identified a public health issue. This deserves to be also monitored in the years to come.

UI MeSH Term Description Entries

Related Publications

Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
October 2007, Veterinary microbiology,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
April 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
April 2022, Vector borne and zoonotic diseases (Larchmont, N.Y.),
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
May 2016, Antimicrobial agents and chemotherapy,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
June 2003, Antimicrobial agents and chemotherapy,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
January 1989, The Journal of antimicrobial chemotherapy,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
April 2020, Antimicrobial agents and chemotherapy,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
October 2010, International journal of antimicrobial agents,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
August 2016, International journal of antimicrobial agents,
Igor Loncaric, and Adriana Cabal Rosel, and Michael P Szostak, and Theresia Licka, and Franz Allerberger, and Werner Ruppitsch, and Joachim Spergser
July 2009, Expert opinion on pharmacotherapy,
Copied contents to your clipboard!